Data as of Jan 30
| +0.05 / +4.59%|
StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA.
|Martin M. McGlynn||President, Chief Executive Officer & Director|
|Gregory T. Schiffman||Chief Financial Officer & Executive Vice President|
|Stephen Huhn||Chief Medical Officer & VP-CNS Clinical Research|
|Ann Tsukamoto||EVP-Scientific & Strategic Alliances|
|Joel Naor||Vice President-Clinical Development|